WuXi Biologics
WuXi Biologics is a global Contract Research, Development & Manufacturing Organization. It is a leading open‑access biologics technology provider. It is experienced in monoclonal, bispecific, multispecific antibodies, fusion proteins, cytokines, enzymes, discovery through commercial‑scale manufacturing, and supporting partners worldwide.
Address: 108 Meiliang Road, Mashan, Binhu District, Wuxi, Jiangsu, China 214092
Phone: (510) 8183-1200
-
Discovery Labs Works on Massive Financing Deal to Settle Debt
Brian O’Neill, developer of Discovery Labs in King of Prussia, is completing a $1 billion financing package to recapitalize Innovation…
-
Penn Medicine Gene Therapy Doctor Signs Deal with Center for Breakthrough Medicines in King of Prussia
University of Pennsylvania Professor James Wilson recently signed a five-year renewable deal on behalf of his gene therapy lab to…
-
Drexel University Considering Moving Its Medical Labs to GSK’s Former Pharmaceutical Plant in Upper Merion
Drexel University is considering moving its medical labs from the former Hahnemann University Hospital campus in Philadelphia to GlaxoSmithKline’s former…
-
Life Science Companies Emerging as Bright Spot in Otherwise Quiet Local Office Market
With traditional office tenants looking for ways to cut back on square footage amid the pandemic, life science companies have…
-
Local Office Markets Thriving As Some Philadelphia Start-Ups Head to Suburbs During Pandemic
Local commercial real estate markets are thriving as a number of Philadelphia start-ups search out more affordable space in the…
-
WuXi Biologics Expects to Add 100 Jobs at Its Newly Leased Space at King of Prussia Discovery Labs
The rapidly-growing biotech company WuXi Biologics has leased space at the Discovery Labs in King of Prussia and is planning…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
